Africa carries 28% of childhood cancers and 38% of the deaths from them

Design

systematic analysis using Global Burden of Disease 2023 methodology and comparative risk assessment, 48 cancer types, 54 countries, 1990-2023, 250 draws per estimate

Population

all ages and both sexes across all 54 African countries

Primary outcome

incidence, mortality, years of life lost, years lived with disability and disability-adjusted life-years, with risk-attributable burden from 88 modifiable risk factors

Effect

1.54 million incident cases (95% UI 1.37-1.75) and 923,000 deaths (824,000-1,020,000) in 2023; childhood cancer 27.7% of global incidence but 38.0% of global deaths; risk-attributable deaths up 216.0% since 1990

The Global Burden of Disease 2023 analysis estimated 48 cancer types across all 54 African countries from 1990 to 2023. In 2023 there were an estimated 1.54 million incident cases (95% uncertainty interval 1.37-1.75 million), 923,000 deaths (824,000-1,020,000) and 33.9 million disability-adjusted life-years, of which 98.2% came from years of life lost rather than years lived with disability.

The paediatric figures are the ones to carry. Africa accounted for 27.7% of global childhood cancer incidence and 38.0% of global childhood cancer deaths — a gap that is entirely about diagnosis and treatment access, since childhood cancer biology does not differ by continent. In women, breast and cervical cancer together made up 53.5% of incident cases. Deaths attributable to the 88 modifiable risk factors assessed rose 216.0% between 1990 and 2023, and now account for a third of cancer deaths.

For an Indian oncologist the relevance is structural rather than geographic. The pattern — a young population, a cancer burden dominated by years of life lost, a third of it attributable to modifiable risk, and childhood outcomes far behind high-income countries — describes a health system at a particular stage rather than a particular place. The interventions the paper points to, prevention and early diagnosis before treatment capacity, apply to any system in that position.

• Childhood cancer survival gaps are an access problem, not a biology problem
• Breast and cervical cancer together account for over half of female cancers — both are screenable
• A third of cancer deaths are attributable to modifiable risk factors as assessed here
• Years of life lost dominate the burden, which argues for early diagnosis over late-line therapy when resources are finite
• Uncertainty intervals are wide because surveillance data are fragmented; these are modelled estimates, not registry counts

Why it matters

It quantifies how much of the childhood cancer survival gap is about access rather than disease.

Don't overread it

Modelled burden estimates built on incomplete surveillance — country-level figures in particular carry substantial uncertainty.

The statistics, in plain English

These are modelled estimates with uncertainty intervals, not counts — the 1.54 million incident cases could plausibly be 1.37 or 1.75 million. That does not weaken the comparative finding: the ratio of 27.7% of global childhood incidence to 38.0% of global childhood deaths comes from the same model and is robust to the absolute numbers being uncertain.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.